Genmab AS

NAS:GMABHealthcareNASDAQ:NBInasdaq_composite

$38.50+4.05%At closeAt close · Tue 20 Oct · ≈ AED 141.39 · Market cap $22.43B · Next earnings Thu 5 Nov · Extended $38.47 −0.08%

Holder	Shares	% out	Change
Paradigm Biocapital Advisors LP	13,133,131	2.2%	+5,165,295
Orbis Allan Gray Ltd	11,368,161	1.9%	−1,557,417
ALLIANCEBERNSTEIN L.P.	8,644,877	1.4%	−912,272
DEERFIELD MANAGEMENT COMPANY, L.P.	6,865,000	1.1%	+4,403,000
Deep Track Capital, LP	5,650,000	0.9%	+1,986,750
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	4,975,324	0.8%	+0
BlackRock, Inc.	4,671,252	0.8%	+134,687
Sofinnova Investments, Inc.	4,045,215	0.7%	+3,292,954
Renaissance Technologies	3,517,850	0.6%	—
RENAISSANCE TECHNOLOGIES LLC	3,517,850	0.6%	−896,700
TWO SIGMA INVESTMENTS, LP	3,506,843	0.6%	+1,167,411
Harding Loevner LP	3,086,318	0.5%	−145,283
FIRST TRUST ADVISORS LP	2,756,522	0.5%	+295,180
CITADEL ADVISORS LLC	2,475,991	0.4%	—
Qube Research & Technologies Ltd	1,689,284	0.3%	+1,011,938